Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00842153 · ClinicalTrials.gov registry record · Phase 4
Evaluation of the Efficacy and Tolerability of Clobetasol Propionate Foam Compared to Vehicle Foam
A Phase 4 study, sponsored by Stiefel, a GSK Company.
- Completed
- Registry status
- Phase 4
- Development phase
- 58
- Enrollment target
NCT00842153 is a Phase 4 study that has completed, run by Stiefel, a GSK Company. The registered enrollment target is 58 participants.
The verdict
NCT00842153, a Phase 4 study, has completed, sponsored by Stiefel, a GSK Company.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 58 participants
- Enrollment target
Study Summary
The purpose of the study is to compare the efficacy and safety of Clobetasol propionate to that of its Vehicle in the treatment of mild to moderate plaque-type psoriasis.
Interventions
- DRUG Vehicle foam
- DRUG Clobetasol propionate foam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2007-11 |
| Est. Completion | 2008-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00842153
The ClinicalTrials.gov registry entry for NCT00842153 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stiefel, a GSK Company, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vehicle foam is the first listed.
NCT00842153 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00842153 about?
NCT00842153 is a clinical study titled "Evaluation of the Efficacy and Tolerability of Clobetasol Propionate Foam Compared to Vehicle Foam". The purpose of the study is to compare the efficacy and safety of Clobetasol propionate to that of its Vehicle in the treatment of mild to moderate plaque-type psoriasis.
What is the current status of trial NCT00842153?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 58 participants. The study started on 2007-11. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00842153?
The interventions under investigation include: Vehicle foam (DRUG), Clobetasol propionate foam (DRUG).
Who is sponsoring clinical trial NCT00842153?
This trial is sponsored by Stiefel, a GSK Company, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.